Molecular Basis for the Interaction of the Mammalian Amino Acid Transporters B0AT1 and B0AT3 with Their Ancillary Protein Collectrin*
暂无分享,去创建一个
Nandhitha Subramanian | Megan L. O'Mara | A. Bröer | S. Bröer | D. Schmoll | M. O’Mara | Dieter Schmoll | Angelika Bröer | Stefan Bröer | Stephen J. Fairweather | N. Subramanian | E. Tumer | Qi Cheng | Emrah Tumer | Qi Cheng | A. Bröer
[1] Simone Moreira de Macêdo,et al. The role of renin-angiotensin system modulation on treatment and prevention of liver diseases , 2014, Peptides.
[2] S. Bröer,et al. Impaired Nutrient Signaling and Body Weight Control in a Na+ Neutral Amino Acid Cotransporter (Slc6a19)-deficient Mouse* , 2011, The Journal of Biological Chemistry.
[3] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[4] L. Forrest,et al. The rocking bundle: a mechanism for ion-coupled solute flux by symmetrical transporters. , 2009, Physiology.
[5] A. Sidhu,et al. Synuclein modulation of monoamine transporters , 2011, FEBS letters.
[6] F. Verrey,et al. Steady-state kinetic characterization of the mouse B0AT1 sodium-dependent neutral amino acid transporter , 2005, Pflügers Archiv.
[7] I. Shimomura,et al. Glucose enhances collectrin protein expression in insulin-producing MIN6 beta cells. , 2009, Biochemical and Biophysical Research Communications - BBRC.
[8] H. Sitte,et al. Oligomerization of neurotransmitter transporters: a ticket from the endoplasmic reticulum to the plasma membrane. , 2006, Handbook of experimental pharmacology.
[9] R. Neubig,et al. A Juxtamembrane Mutation in the N Terminus of the Dopamine Transporter Induces Preference for an Inward-Facing Conformation , 2009, Molecular Pharmacology.
[10] R. MacKinnon,et al. Principles of Selective Ion Transport in Channels and Pumps , 2005, Science.
[11] A. Bröer,et al. Characterization of mouse amino acid transporter B0AT1 (slc6a19). , 2005, The Biochemical journal.
[12] R. Jahn,et al. Core proteins of the secretory machinery. , 2008, Handbook of experimental pharmacology.
[13] H. Wit. Molecular mechanism of secretory vesicle docking , 2010 .
[14] R. Blakely,et al. The N-terminus of the norepinephrine transporter regulates the magnitude and selectivity of the transporter-associated leak current , 2006, Neuropharmacology.
[15] Berk Hess,et al. LINCS: A linear constraint solver for molecular simulations , 1997, J. Comput. Chem..
[16] Ulrik Gether,et al. Regulation of dopamine transporter function by protein‐protein interactions: new discoveries and methodological challenges , 2010, Journal of neurochemistry.
[17] Harini Krishnamurthy,et al. X-ray structures of LeuT in substrate-free outward-open and apo inward-open states , 2012, Nature.
[18] Robert Kleta,et al. Tissue-Specific Amino Acid Transporter Partners ACE2 and Collectrin Differentially Interact With Hartnup Mutations , 2008, Gastroenterology.
[19] M. Quick. The role of SNARE proteins in trafficking and function of neurotransmitter transporters. , 2006, Handbook of experimental pharmacology.
[20] Sebastian Radestock,et al. The alternating-access mechanism of MFS transporters arises from inverted-topology repeats. , 2011, Journal of molecular biology.
[21] K. Fukui,et al. The HNF‐1α‐SNARE connection , 2007 .
[22] R. Carey,et al. Loss of Collectrin, an Angiotensin-Converting Enzyme 2 Homolog, Uncouples Endothelial Nitric Oxide Synthase and Causes Hypertension and Vascular Dysfunction , 2013, Circulation.
[23] A. Bröer,et al. Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19 , 2004, Nature Genetics.
[24] A. Le Bivic,et al. Human syntaxin 3 is localized apically in human intestinal cells. , 1997, Journal of cell science.
[25] D. Warnock,et al. Interaction of syntaxins with epithelial ion channels , 2000, Current opinion in nephrology and hypertension.
[26] Eric Gouaux,et al. X-ray structure of dopamine transporter elucidates antidepressant mechanism , 2013, Nature.
[27] N. Grishin,et al. PROMALS3D: a tool for multiple protein sequence and structure alignments , 2008, Nucleic acids research.
[28] R. Blakely,et al. A Regulated Interaction of Syntaxin 1A with the Antidepressant-Sensitive Norepinephrine Transporter Establishes Catecholamine Clearance Capacity , 2003, The Journal of Neuroscience.
[29] P. Kollman,et al. Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models , 1992 .
[30] M. Quick. Substrates regulate γ-aminobutyric acid transporters in a syntaxin 1A-dependent manner , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[31] W. Gahl,et al. Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder , 2004, Nature Genetics.
[32] S. Bröer,et al. Enterocyte-specific Regulation of the Apical Nutrient Transporter SLC6A19 (B0AT1) by Transcriptional and Epigenetic Networks* , 2013, The Journal of Biological Chemistry.
[33] P. Rosenstiel,et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation , 2012, Nature.
[34] H. Berendsen,et al. Interaction Models for Water in Relation to Protein Hydration , 1981 .
[35] Site-Directed Mutations near Transmembrane Domain 1 Alter Conformation and Function of Norepinephrine and Dopamine Transporters , 2011, Molecular Pharmacology.
[36] M. Freeman,et al. From gene to protein—experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension , 2014, Front. Physiol..
[37] R. Blakely,et al. SNARE-ing neurotransmitter transporters , 2000, Nature Neuroscience.
[38] S. Broer. Diseases associated with general amino acid transporters of the solute carrier 6 family (SLC6). , 2013, Current molecular pharmacology.
[39] Intracellular Domains of a Rat Brain GABA Transporter That Govern Transport , 2004, The Journal of Neuroscience.
[40] J. Penninger,et al. Essential role for collectrin in renal amino acid transport , 2006, Nature.
[41] M. Quick,et al. Transport rates of GABA transporters: regulation by the N-terminal domain and syntaxin 1A , 2000, Nature Neuroscience.
[42] H. Berendsen,et al. Molecular dynamics with coupling to an external bath , 1984 .
[43] L. DeFelice,et al. An N-Terminal Threonine Mutation Produces an Efflux-Favorable, Sodium-Primed Conformation of the Human Dopamine Transporter , 2014, Molecular Pharmacology.
[44] R. Blakely,et al. Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission , 2008, Proceedings of the National Academy of Sciences.
[45] T. Südhof,et al. Pharmacology of neurotransmitter release , 2008 .
[46] Harel Weinstein,et al. A Comprehensive Structure-Based Alignment of Prokaryotic and Eukaryotic Neurotransmitter/Na+ Symporters (NSS) Aids in the Use of the LeuT Structure to Probe NSS Structure and Function , 2006, Molecular Pharmacology.
[47] H. Sitte,et al. Structure and Regulatory Interactions of the Cytoplasmic Terminal Domains of Serotonin Transporter , 2014, Biochemistry.
[48] J. Rasko,et al. A protein complex in the brush‐border membrane explains a Hartnup disorder allele , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[49] S. Bröer,et al. Iminoglycinuria and hyperglycinuria are discrete human phenotypes resulting from complex mutations in proline and glycine transporters. , 2008, The Journal of clinical investigation.
[50] H. Kasai,et al. The HNF-1 target collectrin controls insulin exocytosis by SNARE complex formation. , 2005, Cell metabolism.
[51] B. López-Corcuera,et al. Regulation of glycine transporters. , 2001, Biochemical Society transactions.
[52] Dan Wang,et al. Syntaxin 1A inhibits GABA flux, efflux, and exchange mediated by the rat brain GABA transporter GAT1. , 2003, Molecular pharmacology.
[53] S. Bröer. Epithelial neutral amino acid transporters: lessons from mouse models , 2013, Current opinion in nephrology and hypertension.
[54] Jan Krützfeldt,et al. Tmem27: a cleaved and shed plasma membrane protein that stimulates pancreatic beta cell proliferation. , 2005, Cell metabolism.
[55] B. Egan. Collectrin, an X-linked, angiotensin converting enzyme 2 homolog, causes hypertension in a rat strain through gene-gene and gene-environment interactions: relevance to human hypertension. , 2013, Circulation.
[56] S. Bröer,et al. Mice lacking neutral amino acid transporter B0AT1 (Slc6a19) have elevated levels of FGF21 and GLP-1 and improved glycaemic control , 2015, Molecular metabolism.
[57] S. Amara,et al. Membrane Cholesterol Modulates the Outward Facing Conformation of the Dopamine Transporter and Alters Cocaine Binding* , 2010, The Journal of Biological Chemistry.
[58] N. Guex,et al. SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.
[59] Wilfred F. van Gunsteren,et al. A generalized reaction field method for molecular dynamics simulations , 1995 .
[60] Andreas P. Eichenberger,et al. Definition and testing of the GROMOS force-field versions 54A7 and 54B7 , 2011, European Biophysics Journal.
[61] L. Bao,et al. SNAP-25/Syntaxin 1A Complex Functionally Modulates Neurotransmitter γ-Aminobutyric Acid Reuptake* , 2006, Journal of Biological Chemistry.
[62] Hao Fan,et al. Refinement of homology‐based protein structures by molecular dynamics simulation techniques , 2004, Protein science : a publication of the Protein Society.
[63] S. Bröer. Xenopus laevis Oocytes. , 2010, Methods in molecular biology.
[64] S. Bröer,et al. Intestinal peptidases form functional complexes with the neutral amino acid transporter B0AT1 , 2012, The Biochemical journal.
[65] S. McCall,et al. Aminoaciduria and altered renal expression of luminal amino acid transporters in mice lacking novel gene collectrin. , 2007, American journal of physiology. Renal physiology.
[66] S. Bröer,et al. Renal imino acid and glycine transport system ontogeny and involvement in developmental iminoglycinuria. , 2010, The Biochemical journal.
[67] T. Weimbs,et al. SNARE expression and localization in renal epithelial cells suggest mechanism for variability of trafficking phenotypes. , 2002, American journal of physiology. Renal physiology.
[68] K. Kirk,et al. The Interaction between Syntaxin 1A and Cystic Fibrosis Transmembrane Conductance Regulator Cl− Channels Is Mechanistically Distinct from Syntaxin 1A-SNARE Interactions* , 2003, The Journal of Biological Chemistry.
[69] M. Fox,et al. Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors , 2014, Amino Acids.
[70] Alan E Mark,et al. On the Validation of Molecular Dynamics Simulations of Saturated and cis-Monounsaturated Phosphatidylcholine Lipid Bilayers: A Comparison with Experiment. , 2010, Journal of chemical theory and computation.
[71] J. B. Sørensen. SNARE complexes prepare for membrane fusion , 2005, Trends in Neurosciences.
[72] H. Sitte,et al. Sodium-dependent neurotransmitter transporters: oligomerization as a determinant of transporter function and trafficking. , 2004, Molecular interventions.
[73] M. Quick,et al. Syntaxin 1A up-regulates GABA transporter expression by subcellular redistribution. , 2001, Molecular membrane biology.
[74] D. Meredith,et al. Basigin (CD147) Is the Target for Organomercurial Inhibition of Monocarboxylate Transporter Isoforms 1 and 4 , 2005, Journal of Biological Chemistry.
[75] Berk Hess,et al. Improving Efficiency of Large Time-Scale Molecular Dynamics Simulations of Hydrogen-Rich Systems , 1999 .
[76] M. Stoffel,et al. Tmem27 dimerization, deglycosylation, plasma membrane depletion, and the extracellular Phe-Phe motif are negative regulators of cleavage by Bace2 , 2012, Biological chemistry.
[77] G. Li,et al. Role of SNAREs and H+-ATPase in the targeting of proton pump-coated vesicles to collecting duct cell apical membrane. , 2007, Kidney international.
[78] C. Dominguez,et al. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. , 2003, Journal of the American Chemical Society.
[79] S. Bröer,et al. The solute carrier 6 family of transporters , 2012, British journal of pharmacology.
[80] A. Bröer,et al. Characterization of the monocarboxylate transporter 1 expressed in Xenopus laevis oocytes by changes in cytosolic pH. , 1998, The Biochemical journal.
[81] E. Frohlich,et al. Clinical Perspectives and Fundamental Aspects of Local Cardiovascular and Renal Renin-Angiotensin Systems , 2014, Front. Endocrinol..
[82] M. Caron,et al. Orphan Transporter SLC6A18 Is Renal Neutral Amino Acid Transporter B0AT3* , 2009, The Journal of Biological Chemistry.
[83] M. Caron,et al. Consideration of allosterism and interacting proteins in the physiological functions of the serotonin transporter. , 2012, Biochemical pharmacology.
[84] Eric Gouaux,et al. Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters , 2005, Nature.